Literature DB >> 1889140

Nocturnal melatonin secretion in thyroid disease and in obesity.

S Röjdmark1, A Berg, S Rössner, L Wetterberg.   

Abstract

OBJECTIVE: The purpose was to investigate whether the function of the pinealocytes is changed in patients with disturbed metabolic rate or in subjects with marked obesity.
DESIGN: Venous blood was sampled every second hour between 1800 and 0800 h, and urine collected between 2200 and 0700 h. PATIENTS: Eight patients with thyrotoxicosis, six with primary hypothyroidism, eight with maturity-onset obesity, and 12 healthy controls were included in the study. MEASUREMENTS: Peak serum melatonin values during the night, total nocturnal melatonin secretion (estimated by melatonin incremental areas), and urinary excretion of melatonin were determined in each participant.
RESULTS: Patients with hypothyroidism were found to have higher peak serum melatonin values, total nocturnal melatonin secretion, and urinary excretion of melatonin than normal individuals (Peak melatonin values: 0.55 +/- 0.13 vs 0.27 +/- 0.04 nmol/l, respectively; P less than 0.05. Melatonin incremental areas: 3.38 +/- 0.80 vs 1.45 +/- 0.26 nmol/l h; P less than 0.05. Melatonin excretion: 0.140 +/- 0.023 vs 0.081 +/- 0.013 nmol/9 h; P less than 0.05). Neither of these values differed significantly from the normal in patients with thyrotoxicosis or obesity. Although thyrotoxic patients thus released a normal amount of melatonin during the night, their melatonin secretion peak was phase advanced (melatonin secretion peak appearing at 1.1 +/- 0.5 h in thyrotoxic, and at 3.4 +/- 0.5 h in normal participants; P less than 0.01). No such phase shifts were seen in patients with obesity or hypothyroidism.
CONCLUSIONS: These findings imply that both hypothyroid and thyrotoxic patients have disturbed pineal function, which is not the case in patients with obesity. The mechanism underlying these observations remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889140     DOI: 10.1111/j.1365-2265.1991.tb03497.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

Review 1.  Light, blindness and endocrine secretions.

Authors:  A Bellastella; G Amato; A Bizzaro; C Carella; T Criscuolo; S Iorio; V I Muccitelli; G Pisano; A A Sinisi; A De Bellis
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

3.  The role of somatostatin (octreotide) in the regulation of melatonin secretion in healthy volunteers and in patients with primary hypothyroidism.

Authors:  J Wikner; L Wetterberg; S Röjdmark
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

4.  Night Shift Work Affects Urine Metabolite Profiles of Nurses with Early Chronotype.

Authors:  Markus Rotter; Stefan Brandmaier; Marcela Covic; Katarzyna Burek; Johannes Hertel; Martina Troll; Erik Bader; Jonathan Adam; Cornelia Prehn; Birgit Rathkolb; Martin Hrabe de Angelis; Hans Jörgen Grabe; Hannelore Daniel; Thomas Kantermann; Volker Harth; Thomas Illig; Dirk Pallapies; Thomas Behrens; Thomas Brüning; Jerzy Adamski; Heiko Lickert; Sylvia Rabstein; Rui Wang-Sattler
Journal:  Metabolites       Date:  2018-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.